Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / DNAY - Codex DNA slide continues as shares down ~70% over last month


DNAY - Codex DNA slide continues as shares down ~70% over last month

Shares of Codex DNA (NASDAQ:DNAY) closed down another ~11% today as the synthetic biology company's Q4 2021 results continue to weigh on the stock. Codex DNA (DNAY) released those results after the market close on March 23. Since then through closing Monday, shares are down 55% While maintaining an overweight rating, KeyBanc on Monday cut its price target to $8 from $30 (~94% upside based on Monday's close). The firm cited a collaboration and licensing agreement Codex DNA (DNAY) signed with Pfizer (PFE) in January regarding mRNA vaccines and therapies that could help boost revenue.

For further details see:

Codex DNA slide continues as shares down ~70% over last month
Stock Information

Company Name: Codex DNA Inc.
Stock Symbol: DNAY
Market: NASDAQ

Menu

DNAY DNAY Quote DNAY Short DNAY News DNAY Articles DNAY Message Board
Get DNAY Alerts

News, Short Squeeze, Breakout and More Instantly...